# Carecubes

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/carecubes

- Industry: Medical Devices & Equipment
- Headquarters: San Francisco, US
- Website: www.carecubes.com
- Total disclosed funding: $6.5M
- Latest round: Series A (Mar 19, 2026)
- Investors on record: 2

## About

Based in the US, Carecubes, Inc operates as a healthcare technology company that specializes in infection control solutions, specifically through the development of innovative isolation units.Carecubes, Inc focuses on designing advanced healthcare solutions, particularly the Carecube isolation unit. The company is headquartered in San Francisco, US. On March 19, 2026, Carecubes raised USD 6.5 mn in a Series A funding round led by LifeForce Capital and Schooner Capital, bringing the total amount raised to USD 6.5 mn. The firm has successfully secured one deal to date.Carecubes develops a core product known as the Carecube, a rapid-deployment isolation unit designed to convert standard hospital beds into isolation beds within 10 minutes. This innovative solution addresses the urgent need for effective infection control in healthcare settings, allowing patients to receive safe and compassionate care without the isolation typically associated with infectious diseases. The Carecube is engineered to isolate pathogens, thus minimizing the risk of disease transmission while enabling healthcare providers to maintain regular contact with patients. This product is primarily utilized by hospitals, rural healthcare facilities, and major health systems across a variety of geographical markets, including the United States and potentially global markets that experience infectious disease outbreaks. The company’s client base includes healthcare providers, emergency responders, and public health organizations seeking to enhance their infection control measures.The revenue structure for Carecubes revolves around direct sales of the Carecube isolation units to healthcare providers and institutions. Transactions typically occur on a B2B basis, where hospitals and healthcare systems purchase the units either outright or through contractual agreements that may include maintenance and support services. The business model emphasizes affordability and scalability, with pricing plans designed to cater to different types of healthcare facilities, from smaller rural clinics to larger urban hospitals. This strategic pricing approach enables clients to invest in the Carecube while ensuring access to high-quality infection control solutions. Additionally, the company collaborates with various health organizations and government entities, further expanding its outreach and potential revenue streams from partnerships in public health initiatives.In March 2026, Carecubes, Inc raised USD 6.5 mn in Series A funding from new investors Schooner Capital, LifeForce Capital, and CQuence Health, with participation from individual investors. The company plans to utilize this funding to advance the development of additional healthcare products aimed at improving patient care and infection control. Carecubes is also targeting expansion into new markets, particularly in regions experiencing high rates of infectious diseases, which may include international markets by the end of 2026.

## Funding rounds

- Series A, Mar 19, 2026, $6.5M — Schooner Capital, LifeForce Capital

## Investors

- Schooner Capital (https://capitalatlas.ai/funds/schooner-capital) — Series A
- LifeForce Capital (https://capitalatlas.ai/funds/lifeforce-capital) — Series A